{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:28:13Z","timestamp":1758040093658,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"OrbusNeich Medical, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ahj.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T09:50:35Z","timestamp":1486979435000},"page":"112-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic coronary disease and non\u2013ST-elevation acute coronary syndrome"],"prefix":"10.1016","volume":"187","author":[{"given":"David F.","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Handler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein R.","family":"Al-Khalidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell W.","family":"Krucoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ahj.2017.02.004_bb0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.CIR.103.2.192","article-title":"Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study","volume":"103","author":"Sousa","year":"2001","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ahj.2017.02.004_bb0010","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/hc4201.098056","article-title":"Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up","volume":"104","author":"Sousa","year":"2001","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ahj.2017.02.004_bb0015","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ahj.2017.02.004_bb0020","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ahj.2017.02.004_bb0025","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents: importance of delayed healing","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ahj.2017.02.004_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ahj.2017.02.004_bb0035","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2005.02.086","article-title":"Late angiographic stent thrombosis (LAST) events with drug-eluting stents","volume":"45","author":"Ong","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"5302","key":"10.1016\/j.ahj.2017.02.004_bb0040","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ahj.2017.02.004_bb0045","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2017.02.004_bb0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jcin.2012.10.018","article-title":"The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent","volume":"6","author":"Haude","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"15_S","key":"10.1016\/j.ahj.2017.02.004_bb0055","article-title":"TCT-63 One Year Results of the REMEDEE Registry: clinical outcomes after deployment of the abluminal sirolimus coated bio-engineerd stent in a multicenter, prospective post market registry","volume":"66","author":"de Winter","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.ahj.2017.02.004_bb0060","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2011.08.006","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2017.02.004_bb0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/009286150103500212","article-title":"Statistical methods for comparison to placebo in active-control trials","volume":"35","author":"Hasselblad","year":"2001","journal-title":"Drug Inf J"},{"issue":"1","key":"10.1016\/j.ahj.2017.02.004_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2007.07.084","article-title":"Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials","volume":"51","author":"Pocock","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.004_bb0075","series-title":"Guidance for industry. E6 Good clinical practice: consolidated guidance","first-page":"58","author":"Food and Drug Administration","year":"1996"},{"key":"10.1016\/j.ahj.2017.02.004_bb0080","series-title":"Statement regarding use of ISO 14155:2011 \u201cClinical investigation of medical devices for human subjects\u2014good clinical practice\u201d","first-page":"4","author":"International Medical Device Regulators Forum","year":"2015"},{"issue":"11","key":"10.1016\/j.ahj.2017.02.004_bb0085","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve\u2013guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ahj.2017.02.004_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ahj.2017.02.004_bb0095","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1253\/circj.CJ-12-1431","article-title":"Global cardiovascular device innovation: Japan-USA synergies: Harmonization by Doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions","volume":"77","author":"Uchida","year":"2013","journal-title":"Circ J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317300388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317300388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:58:39Z","timestamp":1757570319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317300388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":19,"alternative-id":["S0002870317300388"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.02.004","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic coronary disease and non\u2013ST-elevation acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}